Sujuan Peng, Hongxiang Huang, Xie Zhu, Jinhong Chen, Xinjing Ding, Fen Wang, Li Chen, Zhihui Lu
{"title":"Anlotinib plus tislelizumab for recurrent metastatic pancreas ductal adenocarcinoma with germline BRCA2 mutation: A case report","authors":"Sujuan Peng, Hongxiang Huang, Xie Zhu, Jinhong Chen, Xinjing Ding, Fen Wang, Li Chen, Zhihui Lu","doi":"10.3892/etm.2024.12466","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":508388,"journal":{"name":"Experimental and Therapeutic Medicine","volume":" 444","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and Therapeutic Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3892/etm.2024.12466","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
